TAP1 Antikörper (Internal Region)
-
- Target Alle TAP1 Antikörper anzeigen
- TAP1 (Transporter 1, ATP-Binding Cassette, Sub-Family B (MDR/TAP) (TAP1))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TAP1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- Antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Immunogen
- TAP1 antibody was raised against a 12 amino acid synthetic peptide near the internal region of TAP1.
- Top Product
- Discover our top product TAP1 Primärantikörper
-
-
- Applikationshinweise
- ELISA: Antibody detection limit dilution 1:32000. Western Blot: Approximately 85 kDa band observed in lysates of cell line MCF7 (calculated MW of 87.2 kDa according to NP_000584.2). Recommended concentration: 1-3 μg/mL.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 500 μg/mL
- Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C.
-
- Target
- TAP1 (Transporter 1, ATP-Binding Cassette, Sub-Family B (MDR/TAP) (TAP1))
- Andere Bezeichnung
- TAP1 (TAP1 Produkte)
- Gen-ID
- 6890
- NCBI Accession
- NP_000584
- UniProt
- Q03518
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-